SK Ca2+-activated K+ channel ligands alter the firing pattern of dopamine-containing neurons in vivo

Neuroscience

Volumn 140, Issue 2, 2006, Pages 623-633

  Ji, H ^a   Shepard, P D ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

1 EBIO; apamin; bursting; ion channels; pacemaker; substantia nigra

Indexed keywords

1 ETHYL 2 BENZIMIDAZOLINONE; APAMIN; CHLORAL HYDRATE; DOPAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; 1-ETHYL-2-BENZIMIDAZOLINONE; BENZIMIDAZOLE DERIVATIVE; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; LIGAND; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ACCURACY; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRODE; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ACTION POTENTIAL; ANIMAL; BIOLOGICAL RHYTHM; CALCIUM SIGNALING; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; APAMIN; BENZIMIDAZOLES; BIOLOGICAL CLOCKS; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM SIGNALING; DOPAMINE; LIGANDS; MALE; NEURONS; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 33646515749     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.020     Document Type: Article

References (75)

1. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7 Suppl 1 (2004) S1-S5
2. Berridge K.C., and Robinson T.E. What is the role of dopamine in reward. hedonic impact, reward learning, or incentive salience?. Brain Res Brain Res Rev 28 (1998) 309-369
3. Bond C.T., Maylie J., and Adelman J.P. Small-conductance calcium-activated potassium channels. Ann N Y Acad Sci 868 (1999) 370-378
4. Bond C.T., Maylie J., and Adelman J.P. SK channels in excitability, pacemaking and synaptic integration. Curr Opin Neurobiol 15 (2005) 305-311
5. Bonta I.L., De Vos C.J., Grijsen H., Hillen F.C., Noach E.L., and Sim A.W. 1-Hydroxy-3-amino-pyrrolidone-2(HA-966). a new GABA-like compound, with potential use in extrapyramidal diseases. Br J Pharmacol 43 (1971) 514-535
6. Bunney B.S., Walters J.R., Roth R.H., and Aghajanian G.K. Dopaminergic neurons. effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185 (1973) 560-571
7. + channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther 296 (2001) 683-689
8. B receptors. J Neurophysiol 74 (1995) 1137-1148
9. Chergui K., Suaud-Chagny M.F., and Gonon F. Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62 (1994) 641-645
10. Coghlan M.J., Gopalakrishnan M., and Carroll W.A. Potassium channel modulators for the treatment of CNS disorders. In: Doherty A. (Ed). Annual reports in medicinal chemistry Vol. 54 (2001), Academic Press, New York 11-20
11. +-channel, on habituation and passive avoidance responses in rats. Neurosci Lett 227 (1997) 57-60
12. Deschaux O., Bizot J.C., and Goyffon M. Apamin improves learning in an object recognition task in rats. Neurosci Lett 222 (1997) 159-162
13. Fiorillo C.D., and Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394 (1998) 78-82
14. Floresco S.B., West A.R., Ash B., Moore H., and Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6 (2003) 968-973
15. Garant D.S., Iadarola M.J., and Gale K. Substance P antagonists in substantia nigra are anticonvulsant. Brain Res 382 (1986) 372-378
16. Garris P.A., Ciolkowski E.L., Pastore P., and Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14 (1994) 6084-6093
17. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24 (1988) 19-28
18. Grace A.A., and Bunney B.S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10 (1983) 301-315
19. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons. burst firing. J Neurosci 4 (1984) 2877-2890
20. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons. single spike firing. J Neurosci 4 (1984) 2866-2876
21. Graybiel A.M., Aosaki T., Flaherty A.W., and Kimura M. The basal ganglia and adaptive motor control. Science 265 (1994) 1826-1831
22. Grunnet M., Jespersen T., Angelo K., Frokjaer-Jensen C., Klaerke D.A., Olesen S.P., and Jensen B.S. Pharmacological modulation of SK3 channels. Neuropharmacology 40 (2001) 879-887
23. Gu X., Blatz A.L., and German D.C. Subtypes of substantia nigra dopaminergic neurons revealed by apamin. autoradiographic and electrophysiological studies. Brain Res Bull 28 (1992) 435-440
24. Habermann E. Apamin. Pharmacol Ther 25 (1984) 255-270
25. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 56 (1998) 507-540
26. Ji H. Effects of 1-ethyl-2-benzimidazolinone (1-EBIO) and apamin on the activity of nigral dopamine-containing neurons in vivo. Soc Neurosci Abstr 185 (2003) 11
27. + currents. Neurosci Lett 231 (1997) 13-16
28. Johnson S.W., Seutin V., and North R.A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate. role of electrogenic sodium pump. Science 258 (1992) 665-667
29. Johnson S.W., and Wu Y.N. Multiple mechanisms underlie burst firing in rat midbrain dopamine neurons in vitro. Brain Res 1019 (2004) 293-296
30. Kita T., Kita H., and Kitai S.T. Electrical membrane properties of rat substantia nigra compacta neurons in an in vitro slice preparation. Brain Res 372 (1986) 21-30
31. Kiyatkin E.A., and Rebec G.V. Heterogeneity of ventral tegmental area neurons. single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience 85 (1998) 1285-1309
32. Lee C.R., Abercrombie E.D., and Tepper J.M. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels. Neuroscience 129 (2004) 481-489
33. Manley L.D., Kuczenski R., Segal D.S., Young S.J., and Groves P.M. Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin. J Neurochem 58 (1992) 1491-1498
34. Matthews R.T., McMillen B.A., Speciale S.G., Jarrah H., Shore P.A., Sanghera M.K., Shepard P.D., and German D.C. Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons. Brain Res Bull 12 (1984) 479-486
35. McMillen B.A., Williams H.L., Lehmann H., and Shepard P.D. On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs. zoxazolamine and HA-966. J Neural Transm Gen Sect 89 (1992) 11-25
36. Menon M.K. Demonstration of the antimyoclonic effect of 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) using a new animal model. Life Sci 28 (1981) 2865-2868
37. + channels, on learning and memory processes. Brain Res 551 (1991) 322-326
38. Morikawa H., Imani F., Khodakhah K., and Williams J.T. Inositol 1,4,5-triphosphate-evoked responses in midbrain dopamine neurons. J Neurosci 20 (2000) RC103
39. 2+ conductances in guinea-pig substantia nigra pars compacta neurones. J Physiol 466 (1993) 727-747
40. Nissbrandt H., Elverfors A., and Engberg G. Pharmacologically induced cessation of burst activity in nigral dopamine neurons. significance for the terminal dopamine efflux. Synapse 17 (1994) 217-224
41. Olpe H.R., Demieville H., Baltzer V., Bencze W.L., Koella W.P., Wolf P., and Haas H.L. The biological activity of d- and l-baclofen (Lioresal). Eur J Pharmacol 52 (1978) 133-136
42. Paladini C.A., Iribe Y., and Tepper J.M. GABAA receptor stimulation blocks NMDA-induced bursting of dopaminergic neurons in vitro by decreasing input resistance. Brain Res 832 (1999) 145-151
43. + channels. J Biol Chem 276 (2001) 9762-9769
44. + channels regulate pacemaker activity in nigral dopamine neurons. Neuroreport 8 (1996) 809-814
45. 2+ chelation evokes bursting plateau potentials in nigral dopamine neurons in vitro. Proc Soc Neurosci 23 (1997) 2111
46. 2+-dependent slow afterdepolarization in nigral dopamine neurons. J Neurophysiol 81 (1999) 977-984
47. Roszkowski A.P. A pharmacological comparison of therapeutically useful centrally acting skeletal muscle relaxants. J Pharmacol Exp Ther 129 (1960) 75-81
48. Sah P., and Faber E.S. Channels underlying neuronal calcium-activated potassium currents. Prog Neurobiol 66 (2002) 345-353
49. Sanghera M.K., Trulson M.E., and German D.C. Electrophysiological properties of mouse dopamine neurons. in vivo and in vitro studies. Neuroscience 12 (1984) 793-801
50. Sarpal D., Koenig J.I., Adelman J.P., Brady D., Prendeville L.C., and Shepard P.D. Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53 (2004) 104-113
51. Schultz W. Getting formal with dopamine and reward. Neuron 36 (2002) 241-263
52. Schultz W. Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology. Curr Opin Neurobiol 14 (2004) 139-147
53. Seutin V., Johnson S.W., and North R.A. Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res 630 (1993) 341-344
54. Seutin V., Massotte L., Scuvee-Moreau J., and Dresse A. Spontaneous apamin-sensitive hyperpolarizations in dopaminergic neurons of neonatal rats. J Neurophysiol 80 (1998) 3361-3364
55. Seutin V., Mkahli F., Massotte L., and Dresse A. Calcium release from internal stores is required for the generation of spontaneous hyperpolarizations in dopaminergic neurons of neonatal rats. J Neurophysiol 83 (2000) 192-197
56. Shepard P.D., and Bunney B.S. Effects of apamin on the discharge properties of putative dopamine-containing neurons in vitro. Brain Res 463 (1988) 380-384
57. + conductance. Exp Brain Res 86 (1991) 141-150
58. Shepard P.D., and Stump D. Nifedipine blocks apamin-induced bursting activity in nigral dopamine-containing neurons. Brain Res 817 (1999) 104-109
59. Shieh C.C., Coghlan M., Sullivan J.P., and Gopalakrishnan M. Potassium channels. molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52 (2000) 557-594
60. Silva N.L., Pechura C.M., and Barker J.L. Postnatal rat nigrostriatal dopaminergic neurons exhibit five types of potassium conductances. J Neurophysiol 64 (1990) 262-272
61. Steketee J.D., and Kalivas P.W. Effect of microinjections of apamin into the A10 dopamine region of rats. a behavioral and neurochemical analysis. J Pharmacol Exp Ther 254 (1990) 711-719
62. Steward O., Tomasulo R., and Levy W.B. Blockade of inhibition in a pathway with dual excitatory and inhibitory action unmasks a capability for LTP that is otherwise not expressed. Brain Res 516 (1990) 292-300
63. + channels. molecular determinants and function of the SK family. Nat Rev Neurosci 5 (2004) 758-770
64. + channels. Am J Physiol Cell Physiol 278 (2000) C570-C581
65. Tepper J.M., Martin L.P., and Anderson D.R. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J Neurosci 15 (1995) 3092-3103
66. van der Staay F.J., Fanelli R.J., Blokland A., and Schmidt B.H. Behavioral effects of apamin, a selective inhibitor of the SK(Ca)-channel, in mice and rats. Neurosci Biobehav Rev 23 (1999) 1087-1110
67. Vartanian M.G., and Taylor C.P. Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo. Neurosci Lett 133 (1991) 109-112
68. Wang R.Y. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res Rev 3 (1981) 123-140
69. Werner G., and Mountcastle V.B. The variability of central neural activity in a sensory system, and its implications for the central reflection of sensory events. J Neurophysiol 26 (1963) 958-977
70. + channels as therapeutic drug targets. Pharmacol Ther 94 (2002) 157-182
71. Willner P. The dopamine hypothesis of schizophrenia. current status, future prospects. Int Clin Psychopharmacol 12 (1997) 297-308
72. Wilson C.J., and Callaway J.C. Coupled oscillator model of the dopaminergic neuron on the substantia nigra. J Neurophysiol 83 (2000) 3084-3100
73. Wilson C.J., Young S.J., and Groves P.M. Statistical properties of neuronal spike trains in the substantia nigra. cell types and their interactions. Brain Res 136 (1977) 243-260
74. Wolfart J., Neuhoff H., Franz O., and Roeper J. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21 (2001) 3443-3456
75. Xia X.M., Fakler B., Rivard A., Wayman G., Johnson-Pais T., Keen J.E., Ishii T., Hirschberg B., Bond C.T., Lutsenko S., Maylie J., and Adelman J.P. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395 (1998) 503-507